AMP Certificate Program: Pharmacogenomics: Genes, Drugs, and Genotyping: AMP Pharmacogenomics Guidelines
This AMP certificate program contains about 4.5 hours of lecture content, the associated pdf slides of the lectures, pre-tests, and post-lecture tests, additional downloadable resources, and an AMP Certificate of Completion. It also includes CME and CMLE credits.
Pharmacogenomics is an important and evolving area of medical testing that combines pharmacology and genomics to identify genomic variability that can affect individual drug response. There is a need in the general medical and laboratory communities to understand the fundamentals of pharmacogenomics and the impacts of molecular testing on optimizing drug selection. This certificate program is intended to provide an introduction to pharmacogenomics and to review AMP expert consensus recommendations for standardization of alleles for clinical pharmacogenomic genotyping assays.
The course contains a pre-test to test your baseline knowledge of the content. It is then followed by presentations by subject matter experts and then a post-test after each section to test your knowledge of the content. It also provides additional useful resources including a resource list fill of links that all pharmacogenomics professionals should know and a Molecular in My PocketTM card outlining the Tier 1 and Tier 2 recommended alleles in one handy worksheet. Finally, case study questions at the end will challenge you to implement what you've learned.
Showcase your knowledge by completing the entire course and passing each post-test with a score of 75% or greater and receiving the AMP Certificate of Completion.
Target Audience: Molecular pathologists, residents, laboratory directors, technologists, and others who have some prior exposure to molecular diagnostic testing. Secondary audiences include oncologists, genetic counselors, primary care clinicians, and other health care professionals.
Topics Covered in Certificate Program: For a detailed outline, click here.
- Introduction to Pharmacogenetics
- Recommendations for Clinical CYP2C19 Genotyping Allele Selection
- Recommendations for Clinical CYP2C9 Genotyping Allele Selection
- Recommendations for Clinical Warfarin Genotyping Allele Selection
Recommendations for Clinical CYP2D6 Genotyping Allele Selection
- Use appropriate nomenclature when describing genes and variants involved in Pharmacogenomics (PGx).
- Describe the application of Association for Molecular Pathology (AMP) PGx Working Group clinical guidelines.
- Outline the importance of standardizing PGx testing across clinical laboratories
- Discuss the key considerations of clinical PGx test development, including gene contents, testing methods, and reference materials.
- Describe and discuss AMP PGx Working Group ‘Tier 1 and 2’ recommended alleles for CYP2C19, CYP2C9, warfarin sensitivity genes, and CYP2D6.
Duration: ~4.5 hours of video
AMP Certificate Program Launched: January 18, 2022
AMP Certificate of Completion Credit available: 4.5 hours
CME/CMLE Credit Available: 4.5 hours
Last day to claim CME or CMLE Credit: December 31, 2023
Last day to complete the course: December 31, 2024
Watch the excerpt from the welcome message from the content director.
|Victoria Pratt, PhD, FACMG
|Karen Weck, MD, FACMG
|Yuan Ji, PhD, MBA, FACMG
|Reynold C. Ly, PhD|
|Jeffrey Kleinberger, MD, PhD
|Stuart A. Scott, PhD, FACMG
||Ann Moyer, MD, PhD
Supported by an educational grant from Illumina . No personally-identifiable information regarding you is provided to any grant supporters.
CONTINUING EDUCATION CREDIT INFORMATIONMaximum CME credit available: 4.50
Maximum CMLE credit available: 4.50
**Continuing Education Credit must be claimed by December 31, 2023
AMA PRA Category 1 Credit(s)™
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 4.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 4.50 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Note: Members of AMP can access this webinar at no cost. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.